Benzinga | Dec 20, 2021 06:26AM EST

HC Wainwright & Co. Initiates Coverage On ProPhase Labs with Buy Rating, Announces Price Target of $12

HC Wainwright & Co. analyst Yi Chen initiates coverage on ProPhase Labs (NASDAQ:PRPH) with a Buy rating and announces Price Target of $12.